TCI Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TCI Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-469	Closed	-$35.7K	–	2274
2023 Q1	$35.7K	Hold	469	–	–	﹤0.01%	516
2022 Q4	$38.9K	Hold	469	–	–	0.01%	473
2022 Q3	$37K	Hold	469	–	–	0.01%	457
2022 Q2	$35K	Hold	469	–	–	0.01%	472
2022 Q1	$42K	Hold	469	–	–	0.01%	459
2021 Q4	$53K	Hold	469	–	–	0.01%	400
2021 Q3	$59K	Hold	469	–	–	0.01%	379
2021 Q2	$64K	Buy	469 +160	+52%	+$21K	0.01%	343
2021 Q1	$42K	Hold	309	–	–	0.02%	387
2020 Q4	$44K	Hold	309	–	–	0.02%	363
2020 Q3	$34K	Hold	309	–	–	0.01%	368
2020 Q2	$35K	Buy	+309	New	+$30.4K	0.02%	364
2019 Q4	–	Sell	-15	Closed	-$1K	–	1702
2019 Q3	$1K	Buy	+15	New	+$1.25K	﹤0.01%	1411
2018 Q4	–	Sell	-12	Closed	-$1K	–	1683
2018 Q3	$1K	Sell	12 -7	-37%	-$679	﹤0.01%	1355
2018 Q2	$2K	Buy	+19	New	+$1.75K	﹤0.01%	1168
2014 Q4	–	Sell	-300	Closed	-$16K	–	933
2014 Q3	$16K	Buy	+300	New	+$15.3K	0.01%	366

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

TCI Wealth Advisors's XBI Position: Q2 2023 in Review

TCI Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 469 shares — an estimated $35.7K sold.

TCI Wealth Advisors first reported a position in XBI in Q3 2014 and held it in 16 quarters. The position peaked at $64K in Q2 2021. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

TCI Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 469 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $35.7K.
TCI Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and held it in 16 quarters.
TCI Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $64K in Q2 2021.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.